Biora Therapeutics Showcases Progress On BioJet Oral Delivery Platform With Largest Payload Capacity Among Ingestible Injectables At PODD Meeting; Smaller 00-Size Device Advances In Animal Models With Full Testing Expected In Q4 2024
Author: Benzinga Newsdesk | October 28, 2024 08:13am